IDiyas

For the Inventor, By the Inventor

Norwalk, CT, United States of America

Sivaraman Raghu

USPTO Granted Patents = 21

Average Co-Inventor Count = 1.8

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:

goldMedal20 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal1 out of 1 
 
Cyanamid Agricultural De Puerto Rico, Inc.
 patent

Years Active: 1978-1986

Loading Chart...
21 patents (USPTO):Explore Patents
1. 4620009 - Synthesis of intermediates for tetramisole, levamisole and their (1986-10-28),
2. 4499283 - Process for preparing (1985-02-12),
3. 4459413 - Process for preparing 5-imidazolyl ketones (1984-07-10),
4. 4439611 - Isolation of [S-(R*, (1984-03-27),
5. 4408072 - Amido methoxyethylamines (1983-10-04),
6. 4405529 - Method for the preparation of difluoromethoxyaromatic compounds (1983-09-20),
7. 4395547 - Process for preparing (1983-07-26),
8. 4370482 - Synthesis of tetramisole, levamisole and their derivatives (1983-01-25),
9. 4339603 - Process for converting optically active (1982-07-13),
10. 4316038 - 1-(2-Methoxyethyl)-2-methyl-4-phenyl-2-imidazoline (1982-02-16),
11. 4314079 - Novel methoxyethylamine (1982-02-02),
12. 4314066 - Synthesis of tetramisole, levamisole and their derivatives (1982-02-02),
13. 4310672 - Synthesis of intermediates for tetramisole, levamisole and their (1982-01-12),
14. 4245103 - Processes for the preparation of tetramisole (1981-01-13),
15. 4245102 - Processes for the preparation of tetramisole (1981-01-13),

Title: The Innovative Contributions of Sivaraman Raghu

Introduction: Sivaraman Raghu, based in Norwalk, CT, is a prolific inventor with an impressive portfolio of 21 patents. His work primarily focuses on the synthesis of various compounds that have significant applications in pharmaceuticals, particularly as intermediates for therapeutic agents.

Latest Patents: Among his latest contributions to the field, Raghu has developed processes for the synthesis of intermediates for tetramisole and levamisole, which are crucial in the manufacture of effective anthelmintic drugs. He has also patented processes for the production of 1-(2-alkoxyethyl)-4-phenyl-4-imidazolin-2-ones and related compounds, which serve as intermediates in the development of new therapeutic agents, including anti-asthmatic medications. His innovative approach includes protocols for preparing 2-(n-propyl)-4-methyl-5-(lower alkanoyl)imidazoles, which have valuable applications in the formulation of drugs for asthma treatment.

Career Highlights: Throughout his career, Sivaraman Raghu has made significant contributions while working with notable companies such as American Cyanamid Company and Cyanamid Agricultural de Puerto Rico, Inc. His dedication to advancing pharmaceutical science is reflected in his extensive patent portfolio and ongoing research efforts.

Collaborations: Raghu has collaborated with distinguished professionals in the field, including Arthur K. Hoffmann and Balwant Singh. These collaborations have propelled his research initiatives and have been instrumental in the successful development of several patented processes.

Conclusion: Sivaraman Raghu exemplifies the spirit of innovation within the pharmaceutical industry, with his 21 patents underscoring his commitment to enhancing drug development. His work continues to have a profound impact on the healthcare landscape, making strides toward effective therapeutic solutions for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…